Pfiz­er is dou­bling down on its com­mit­ment to Chi­na as the com­pa­ny con­tin­ues to face ac­tivist pres­sure around its ...
The head of As­traZeneca’s op­er­a­tions in Chi­na has been de­tained by au­thor­i­ties there, the com­pa­ny con­firmed.
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get ...